1 |
Xiao Q, Tang Y, Luo H, Chen S, Tang Q, Chen R, Xiong L, Xiao J, Hong D, Wang L, Li G, Li Y. Inositol 1,4,5-trisphosphate receptor type 2 is associated with the bone-vessel axis in chronic kidney disease-mineral bone disorder. Ren Fail 2023;45:2162419. [PMID: 36645057 DOI: 10.1080/0886022X.2022.2162419] [Reference Citation Analysis]
|
2 |
Schulte A, Blum R. Shaped by leaky ER: Homeostatic Ca2+ fluxes. Front Physiol 2022;13:972104. [DOI: 10.3389/fphys.2022.972104] [Reference Citation Analysis]
|
3 |
Metzner V, Herzog G, Heckel T, Bischler T, Hasinger J, Otto C, Fassnacht M, Geier A, Seyfried F, Dischinger U. Liraglutide + PYY3-36 Combination Therapy Mimics Effects of Roux-en-Y Bypass on Early NAFLD Whilst Lacking-Behind in Metabolic Improvements. JCM 2022;11:753. [DOI: 10.3390/jcm11030753] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
4 |
Dischinger U, Heckel T, Bischler T, Hasinger J, Königsrainer M, Schmitt-Böhrer A, Otto C, Fassnacht M, Seyfried F, Hankir MK. Roux-en-Y Gastric Bypass and Caloric Restriction but Not Gut Hormone-Based Treatments Profoundly Impact the Hypothalamic Transcriptome in Obese Rats. Nutrients 2021;14:116. [PMID: 35010991 DOI: 10.3390/nu14010116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|